Biography
Dr. Rita Mukhtar specializes in breast surgery and general surgery for urgent conditions. For her patients with breast cancer, she offers expertise in total skin-sparing mastectomies, breast conservation, wire localization surgery (used to show the location of tissue requiring biopsy) and sentinel lymph node biopsy (used to see if cancer has spread).
Dr. Mukhtar's research program focuses on invasive lobular carcinoma, the second most common type of breast cancer. This work is funded by the American Cancer Society and the National Cancer Institute. She teaches medical students and residents, and serves as an Associate Program Director for the UCSF General Surgery Residency.
Dr. Mukhtar's research program focuses on invasive lobular carcinoma, the second most common type of breast cancer. This work is funded by the American Cancer Society and the National Cancer Institute. She teaches medical students and residents, and serves as an Associate Program Director for the UCSF General Surgery Residency.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of California | Diversity, Equity, and Inclusion Champion Training | 2018 | |
University of California, San Francisco | M.D. | Medicine | 2006 |
Board Certifications
American Board of Surgery, General Surgery
Clinical Expertise
Breast Surgery
Lumpectomy
Seed and wire localization surgery
Nipple sparing/total skin sparing mastectomy
Sentinel lymph node biopsy
Axillary dissection
Emergency General Surgery
Clinical Trials
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles (NCT03053193)Related Conditions: Breast Cancer| Start Date: | End Date:
- Related Conditions: Breast Cancer| Start Date: | End Date:
- Related Conditions: Breast Cancer| Start Date: | End Date:
- Related Conditions: Breast Cancer, Carcinoma| Start Date: | End Date:
Program Affiliations
Carol Franc Buck Breast Care Center
In the News
October, 27, 2020 | UCSF Department of Surgery
October, 01, 2020 | UCSF Department of Surgery
July, 10, 2020 | UCSF Department of Surgery
December, 11, 2019 | UCSF Breastcare Program
May, 26, 2017 | UCSF Department of Surgery
Research Pathways
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 166
- ASO Visual Abstract: Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and is Common in Patients with HER2+ Breast Cancer.| | PubMed
- ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.| | PubMed
- Reply to: "Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium and the National Cancer Database (NCDB)".| | PubMed
- Variation in surgical treatment by body mass index in patients with invasive lobular carcinoma of the breast.| | PubMed
- Therapeutic response and outcomes with uncommon breast cancer subtypes in the I-SPY trial 2010-2022.| | UCSF Research Profile
- Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.| | PubMed
- Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situ.| | PubMed
- ASO Visual Abstract: Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy-Results from the I-SPY2 Clinical Trial.| | PubMed
- ASO Visual Abstract: Surveillance Strategies After Primary Treatment for Patients with Invasive Lobular Carcinoma of the Breast-Method of Local Recurrence Detection After Breast Conserving Surgery.| | PubMed
- ASO Visual Abstract: Oncologic Safety of Immediate Oncoplastic Surgery Compared to Standard Breast Conserving Surgery for Patients with Invasive Lobular Carcinoma.| | PubMed
- ASO Author Reflections: Evolving Paradigms in Axillary Management for Breast Cancer: Insights from the ISPY-2 Neoadjuvant Chemotherapy Trial.| | PubMed
- ASO Author Reflections: Detecting Local Recurrence After Primary Treatment for Invasive Lobular Carcinoma of the Breast.| | PubMed
- International survey on invasive lobular breast cancer identifies priority research questions.| | PubMed
- Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.| | PubMed
- Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.| | PubMed
- Surveillance Strategies After Primary Treatment for Patients with Invasive Lobular Carcinoma of the Breast: Method of Local Recurrence Detection After Breast-Conserving Surgery.| | PubMed
- Elucidating the immune active state of HR+HER2- MammaPrint High 2 early breast cancer.| | UCSF Research Profile
- Impact of extent of disease at presentation on oncologic outcomes according to pathologic response to neoadjuvant systemic therapy among participants of the I-SPY2 clinical trial.| | UCSF Research Profile
- The neoadjuvant approach to treatment of breast cancer: Multidisciplinary management to improve outcomes.| | UCSF Research Profile
- Therapeutic response and outcomes with less common breast cancer subtypes in the I-SPY trial 2011-2022.| | UCSF Research Profile
- I-SPY2 Endocrine Optimization Pilot (EOP): Neoadjuvant amcenestrant +/- abemaciclib +/- letrozole in molecularly selected patients (pts) with HR+ HER2- stage 2/3 breast cancer (BC).| | UCSF Research Profile
- Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment.| | PubMed
- ASO Author Reflections: The Oncologic Safety of Immediate Oncoplastic Approaches in Invasive Lobular Carcinoma.| | PubMed
- Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma.| | PubMed
- Abstract PO4-02-03: Distribution of MammaPrint, BluePrint, and Response Predictive Subtypes based on ImPrint and Reprint in ER+/HER2- Invasive Lobular Carcinoma – A FLEX sub study.| | UCSF Research Profile
- Abstract PO5-26-07: Surgery for Invasive Lobular Carcinoma: A Patient Experience Survey from the Lobular Breast Cancer Alliance.| | UCSF Research Profile
- Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis.| | PubMed
- Abstract A059: Heterogeneous cell populations in organoid models derived from breast preinvasive and invasive carcinomas after endocrine therapy.| | UCSF Research Profile
- Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma.| | PubMed
- Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer risk.| | PubMed
- ASO Visual Abstract: Nipple-Sparing Mastectomies in Patients over the Age of 60 Years: Factors Associated with Surgical Outcomes.| | PubMed
- Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants.| | PubMed
- ASO Visual Abstract: Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.| | PubMed
- Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer.| | PubMed
- Letter to the Editor of Annals of Surgical Oncology concerning "Is Choosing Wisely Wise for Lobular Carcinoma in Patients over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns".| | PubMed
- The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB).| | PubMed
- 356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study.| | UCSF Research Profile
- Erratum: 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression - CORRIGENDUM.| | PubMed
- Nipple-Sparing Mastectomies in Patients over the Age of 60 Years: Factors Associated with Surgical Outcomes.| | PubMed
- ASO Author Reflections: Menopausal Status Does Not Predict Successful Breast Conservation Surgery After Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma.| | PubMed
- Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment.| | PubMed
- Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.| | PubMed
- Quantifying hormone receptor status in lobular breast cancer in an institutional series: the relationship between estrogen and progesterone receptor status and outcomes.| | PubMed
- The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database.| | PubMed
- Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy.| | PubMed
- ASO Author Reflections: Patient, Tumor, and Treatment Characteristics Predict Early Versus Late Recurrence in Patients with Invasive Lobular Carcinoma of the Breast.| | PubMed
- Editorial: Contrast mammography-a promising tool for the pre-operative evaluation of lobular breast cancer.| | PubMed
- Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.| | PubMed
- Metabolic Positron Emission Tomography in Breast Cancer.| | PubMed
- Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 Trial.| | PubMed
- Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy-Reply.| | PubMed
- Time to Surgery in Breast Cancer-Is Faster Always Better?| | PubMed
- 407 Moving from observational studies to a clinical trial: the impact of obesity and surgical weight loss on breast imaging, tissue, and cancer screening experience: the B-BRITE study.| | UCSF Research Profile
- 53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression.| | UCSF Research Profile
- HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.| | PubMed
- Abstract HER2-14: HER2-14 HER-2 low status in early stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.| | UCSF Research Profile
- Abstract P2-03-16: Quantifying estrogen and progesterone receptor status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series.| | UCSF Research Profile
- Abstract P3-09-01: Characterization of residual disease after neoadjuvant selective estrogen receptor degrader (SERD) therapy using tumor organoids in the I-SPY Endocrine Optimization Protocol (EOP).| | UCSF Research Profile
- Abstract P6-05-10: An international survey on invasive lobular breast cancer (ILC) reveals gaps in knowledge and top priority research areas.| | UCSF Research Profile
- Abstract P6-08-09: Self-identified race and Area Deprivation Index in patients with invasive lobular carcinoma of the breast: associations with tumor characteristics and event free survival.| | UCSF Research Profile
- Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior.| | PubMed
- Expanding Candidacy for Nipple-sparing Mastectomy in Women with Large or Ptotic Breasts: Staged Reconstruction Outcomes.| | PubMed
- Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort.| | PubMed
- Implementation, evaluation, and modification of a near-peer learning group in graduate surgical education.| | PubMed
- ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study.| | PubMed
- Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial.| | PubMed
- Hereditary vs Sporadic Invasive Lobular Carcinoma and Impact of Locoregional Therapy on Disease-Free Survival.| | UCSF Research Profile
- Molecular Imaging for Estrogen Receptor-Positive Breast Cancer: Clinical Applications of Whole Body and Dedicated Breast Positron Emission Tomography.| | PubMed
- See one, do one, teach one: a flipped classroom to make quality improvement experiential in surgical residency.| | UCSF Research Profile
- The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study.| | PubMed
- ASO Author Reflections: Discordant Clinical and Molecular Risk in Invasive Lobular Carcinoma of the Breast: The 21-Gene Recurrence Score in the National Cancer Database by Histologic Subtype.| | PubMed
- Abstract LB021: Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer progression.| | UCSF Research Profile
- Pathologic complete response (pCR) rates for HR+/HER2- breast cancer by molecular subtype in the I-SPY2 Trial.| | UCSF Research Profile
- Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer-Reply.| | PubMed
- Emotional Regulation in Surgery: Fostering Well-Being, Performance, and Leadership.| | PubMed
- Abstract OT1-10-02: I-SPY2 endocrine optimization protocol (EOP): A pilot neoadjuvant endocrine therapy study with amcenestrant as monotherapy or in combination with abemacicilib or letrozole in molecularly selected HR+/HER2- clinical stage 2/3 breast can| | UCSF Research Profile
- Abstract P2-02-02: Differences in levels of circulating tumor cells (CTC) and disseminated tumor cells (DTC) in early-stage lobular versus ductal breast cancer.| | UCSF Research Profile
- Abstract P3-02-01: Initial experience of FES-dedicated breast PET imaging of early-stage ER+ invasive lobular carcinoma.| | UCSF Research Profile
- Abstract P3-02-02: FES-dedicated breast PET uptake in early-stage ER+ breast cancers.| | UCSF Research Profile
- Abstract P3-03-07: Single-institution retrospective analysis of lymph node (LN) change on breast MRI in patients with high risk early-stage breast cancer receiving neoadjuvant chemotherapy with and without immunotherapy on the ISPY-2 TRIAL.| | UCSF Research Profile
- The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study.| | PubMed
- O13 BIOLOGIC VERSUS SYNTHETIC MESH IN VENTRAL HERNIA REPAIR: PARTICIPANT-LEVEL ANALYSIS OF TWO RANDOMIZED CONTROLLED TRIALS AT ONE YEAR.| | UCSF Research Profile
- Obesity and menopausal status impact the features and molecular phenotype of invasive lobular breast cancer.| | PubMed
- Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?| | PubMed
- Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.| | PubMed
- Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief.| | PubMed
- Correction to: Applications of 3D printing in breast cancer management.| | PubMed
- Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies.| | PubMed
- Decreased enrollment of patients with advanced lobular breast cancer compared to ductal breast cancer in interventional clinical trials.| | UCSF Research Profile
- Early onset, multiple, bilateral fibroadenomas of the breast: a case report.| | PubMed
- Invasive Lobular Carcinoma of the Breast: Ongoing Trials, Challenges, and Future Directions.| | UCSF Research Profile
- Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial.| | PubMed
- Relationship between body mass index and malignancy rates of MRI-guided breast biopsies: impact of clinicodemographic factors.| | PubMed
- ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response.| | PubMed
- Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB).| | PubMed
- Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma.| | PubMed
- Abstract PD5-01: Magnetic resonance imaging insights from an active surveillance cohort of women with DCIS.| | UCSF Research Profile
- Abstract PD6-08: DCE-MRI derived imaging features for characterizing invasive lobular breast cancer and predicting recurrence-free survival after neoadjuvant therapy.| | UCSF Research Profile
- Abstract PS1-03: Active surveillance for DCIS: Clinical outcomes at 5.6 years mean follow-up.| | UCSF Research Profile
- Abstract PS17-05: Relationship between body mass index and tumor subtype by menopausal status: An analysis in women with lobular carcinoma of the breast.| | UCSF Research Profile
- Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.| | PubMed
- Applications of 3D printing in breast cancer management.| | PubMed
- A world-wide survey on kidney transplantation practices in breast cancer survivors: The need for new management guidelines.| | PubMed
- Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast: Factors associated with false negatives.| | PubMed
- Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217.| | PubMed
- Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience.| | PubMed
- 274 Poster Unintended bias in clinical trials: The prevalence of entry criteria that exclude patients with invasive lobular carcinoma from metastatic breast cancer trials.| | UCSF Research Profile
- Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast.| | PubMed
- Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater.| | PubMed
- Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy.| | PubMed
- 4314 The Impact of Axillary Surgery on Recurrence-Free Survival in Invasive Lobular Carcinoma (ILC) of the Breast.| | UCSF Research Profile
- Accuracy of sentinel lymph node biopsy in invasive lobular carcinoma of the breast.| | UCSF Research Profile
- Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival.| | PubMed
- Abstract P3-08-16: The impact of residual ductal carcinoma in situ on breast cancer recurrence in the neoadjuvant I-SPY2 TRIAL.| | UCSF Research Profile
- Abstract P4-13-01: Trends in primary management of invasive lobular carcinoma: An analysis of the National Cancer Database (NCDB).| | UCSF Research Profile
- Abstract P5-08-05: Risk of subsequent events after initial diagnosis of ductal carcinoma in situ - A large multi-center registry study.| | UCSF Research Profile
- Abstract P6-16-06: Improved early stratification of invasive cancer risk using MRI in a ductal carcinoma in-situ short-term active surveillance cohort treated with neoadjuvant endocrine therapy.| | UCSF Research Profile
- Abstract PD9-08: Accuracy of ultrasound in evaluating response to neoadjuvant therapy in invasive lobular carcinoma of the breast.| | UCSF Research Profile
- Pragmatic Trials and Approaches to Transforming Care.| | UCSF Research Profile
- Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study.| | PubMed
- Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast.| | PubMed
- Editorial: Applying Margin Consensus Guidelines to Invasive Lobular Carcinoma of the Breast.| | PubMed
- Feasibility of Magnetic Seeds for Preoperative Localization of Axillary Lymph Nodes in Breast Cancer Treatment.| | PubMed
- Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.| | PubMed
- Synchronous Breast Implant-associated Anaplastic Large Cell Lymphoma and Invasive Carcinoma: Genomic Profiling and Management Implications.| | PubMed
- Abstract 118: The Impact of Post-Operative Prophylactic Antibiotics in Immediate 2-Stage Prepectoral Breast Reconstruction.| | UCSF Research Profile
- Changes in mammographic density following bariatric surgery.| | PubMed
- Abstract P1-15-15: Accuracy of MRI after neoadjuvant therapy for invasive lobular carcinoma of the breast.| | UCSF Research Profile
- Abstract P4-11-01: A simple intervention for long-term relief of chronic post mastectomy pain.| | UCSF Research Profile
- Abstract P6-01-04: Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.| | UCSF Research Profile
- Abstract PD7-06: Molecular subtypes of invasive lobular breast cancer in the I-SPY2 TRIAL.| | UCSF Research Profile
- Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.| | PubMed
- Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents.| | PubMed
- ASO Author Reflections: Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.| | PubMed
- Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.| | PubMed
- Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients.| | PubMed
- 452 (PB-085) The impact of mitotic score versus pleomorphic subtype on disease free survival in invasive lobular carcinoma of the breast.| | UCSF Research Profile
- Abstract P2-12-16: The use of oncoplastic surgical techniques to increase successful breast conservation in invasive lobular carcinoma of the breast.| | UCSF Research Profile
- Abstract P5-12-04: The impact of bariatric surgery on mammographic breast density.| | UCSF Research Profile
- Abstract P5-22-22: Breast tumor location in BRCA mutation carriers and implications for prevention.| | UCSF Research Profile
- Breast tumor location in BRCA mutation carriers and implications for prevention.| | UCSF Research Profile
- Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.| | PubMed
- The Novel Application of Genomic Profiling Assays to Shorten Inactive Status for Potential Kidney Transplant Recipients With Breast Cancer.| | PubMed
- How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer.| | PubMed
- Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care.| | PubMed
- Abstract PD1-5: Characterizing the Tumor Immune MicroEnvironment (TIME) in high-risk ductal carcinoma in situ.| | UCSF Research Profile
- The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context.| | PubMed
- Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).| | PubMed
- Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.| | PubMed
- Biology of breast cancer in Nigerian women: a pilot study.| | PubMed
- Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.| | PubMed
- P1-06-10: Lobular Breast Cancer and NAC: Combined Results from the NKI and I-SPY 1 Trial.| | UCSF Research Profile
- P4-09-19: PCNA+ Tumor Associated Macrophages Are Associated with M1 and M2 Gene Expression, and Confer Poor Prognosis in the Absence of Anti-Tumor Immune Environment.| | UCSF Research Profile
- PD02-05: MRI Phenotype and Tumor Subtype Affect Breast Conservation Eligibility and MRI Accuracy in the I-SPY 1 Trial.| | UCSF Research Profile
- Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity.| | PubMed
- Identification of pathogenic macrophages in breast cancer as markers of tumor aggressiveness.| | UCSF Research Profile
- Benign Thoracic Disease in the Elderly.| | UCSF Research Profile
- Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics.| | PubMed
- Abstract P2-09-11: Response of Invasive Lobular Cancers to Neoadjuvant Therapy.| | UCSF Research Profile
- Evaluation of levels of proliferating macrophages in patients at a county hospital and those with early recurrences.| | UCSF Research Profile
- Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequence.| | PubMed
- Bacteriologic features of surgical site infections following breast surgery.| | PubMed
- Benign thoracic disease in the elderly.| | PubMed
- Variation in annual volume at a university hospital does not predict mortality for pancreatic resections.| | PubMed
- Image of the month--quiz case. Traumatic intramuscular cyst of the duodenum.| | PubMed
- Quality-of-life issues in psoriasis.| | PubMed